肾病综合征预防性抗凝的系统综述
该系统综述检索了1990至2019年MEDLINE、EMBASE和COCHRANE数据库,最终纳入28篇文章,讨论成人肾病综合征患者预防性抗凝的対象、时机和方法。作者基于现有证据扩展了KDIGO指南,并构建了辅助决策的临床算法。
要点
- 肾病综合征患者静脉和动脉血栓栓塞风险增高,可高达40%。
- 2012年KDIGO指南仅推荐特发性膜性肾病患者进行预防性抗凝。
- 作者基于证据扩展KDIGO指南并构建预防性抗凝决策算法。
核心结论
- 基于现有证据扩展了当前KDIGO指南,并构建了肾病综合征预防性抗凝的临床决策算法。
研究设计与样本
- 系统检索MEDLINE、EMBASE和COCHRANE数据库1990至2019年相关文献,筛查2381篇,全文复习51篇,最终纳入28篇。
主要发现
- 肾病综合征患者静脉和动脉血栓栓塞风险增高,可高达40%,取决于严重程度和基础病因。
- 2012年KDIGO指南仅推荐特发性膜性肾病患者进行预防性抗凝,并承认现有数据有限且质量低。
临床怎么用
- 使用作者构建的临床算法辅助决定成人肾病综合征患者是否、何时及如何预防性抗凝。
局限性
- 现有数据有限且质量低,需要更好识别高危患者以平衡抗凝风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Nephrotic syndrome is associated with an increased risk of venous and arterial thromboembolism, which can be as high as 40% depending on the severity and underlying cause of nephrotic syndrome. The 2012 Kidney Disease: Improving Global Outcomes (KDIGO) guidelines recommend prophylactic anticoagulation only in idiopathic membranous nephropathy but acknowledge that existing data are limited and of low quality. There is a need for better identification of vulnerable patients in order to balance the risks of anticoagulation. METHODS: We undertook a systematic search of the topic in MEDLINE, EMBASE and COCHRANE databases, for relevant articles between 1990 and 2019. RESULTS: A total of 2381 articles were screened, with 51 full-text articles reviewed. In all, 28 articles were included in the final review. CONCLUSION: We discuss the key questions of whom to anticoagulate, when to anticoagulate, and how to prophylactically anticoagulate adults with nephrotic syndrome. Using available evidence, we expand upon current KDIGO guidelines and construct a clinical algorithm to aid decision making for prophylactic anticoagulation in nephrotic syndrome.
引用
- Lin R, McDonald G, Jolly T, et al. A Systematic Review of Prophylactic Anticoagulation in Nephrotic Syndrome. Kidney Int Rep. 2019. PMID: 32274450. doi:10.1016/j.ekir.2019.12.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。